Navigation Links
Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility
Date:2/21/2008

Summary: Genmab and PDL BioPharma Have Entered into an Agreement Under Which Genmab Will Acquire PDL's Antibody Manufacturing Facility Located in

Brooklyn Park, Minnesota, USA

COPENHAGEN, Denmark and REDWOOD CITY, California, February 21 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) and PDL BioPharma, Inc. (Nasdaq: PDLI) announced today that they have entered into an agreement under which Genmab would acquire PDL's antibody manufacturing facility located in Brooklyn Park, Minnesota, USA for USD 240 million to be paid in cash. The transaction also includes land, equipment and access to a leased space housing a development lab.

Genmab expects the Minnesota facility, which has a production capacity of 22,000 liters, will be sufficient to provide a sustainable source of both clinical and commercial scale material for its pipeline. The facility features two 1,000 liter and two 10,000 liter bioreactors, which support the simultaneous manufacture of multiple antibody products and will enable Genmab to transition three antibodies from research to manufacturing per year.

"Over the past few years Genmab has been preparing for the market launch of our late stage antibodies and we continue to build a broad pipeline of antibody products, which currently includes 10 products in clinical development. Consequently, the need to secure significant manufacturing capacity has become an increasing priority," stated Lisa N. Drakeman, Ph.D., Chief Executive Officer of Genmab. "We believe that the new PDL manufacturing facility, with its complete antibody process development platform, represents our best option to secure manufacturing capacity, allowing Genmab to produce antibodies more efficiently and cost effecti
'/>"/>

SOURCE Genmab A/S
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Medarex Announces Completion of Sale of Shares in Genmab A/S
2. Genmabs Financial Calendar for 2008
3. Genmab Reaches Milestones in Ofatumumab Collaboration
4. Genmab Announces HuMax-CD32b Pre-Clinical Program
5. Roche Files IND for Second Genmab Antibody
6. Genmab A/S - R1507 Antibody to Enter Phase II Study to Treat Sarcoma
7. Genmab Announces Details of Planned Ofatumumab Phase II Study in Multiple Sclerosis
8. Fourth Genmab Antibody Developed Under Roche Collaboration to Enter Clinic
9. Genmab Announces Update on Recruitment of Patients in ofatumumab CLL Pivotal Study
10. Genmab Announces Results for the First Nine Months of 2007
11. Phase I Results Announced for R1507 From Genmabs Collaboration With Roche
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... -- Replikins Ltd. today released new data on changes in ... current outbreaks, the mean Ebola Reston gene Replikin Count ... and 2002 was 1.1; the mean Replikin Count increased ... 2013, thus predicting the current outbreaks in humans. ... to be able to predict outbreaks (1).  For example, ...
(Date:7/30/2014)... Sales Horizons, a leader in sales training ... programs for companies engaged in complex B2B sales. , ... of salespeople over 25 years in market-leading Fortune 500 ... customized to address the unique sales challenges of companies ... program consists of two parts: Mastering the Complex ...
(Date:7/30/2014)... July 30, 2014. Applied DNA Sciences, ... provides DNA-based authentication and security solutions and services, has ... Life Sciences, a newly created position, with a starting ... lead APDN’s drive to build its business in pharmaceuticals ... customers, provide guidance to APDN’s R&D efforts, and apply ...
(Date:7/30/2014)... Yuma Regional Cancer Center Officially ... brings comprehensive cancer care to Yuma, Arizona. , ... Center has officially opened. A Mayo Clinic Care ... such as open, semi-private and private infusion rooms, ... Resource Center, hematology, rehabilitation center, a pain management ...
Breaking Biology Technology:Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 2Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 3Dr. Michael E. Hogan, Ph.D., Joins Applied DNA Sciences as Vice President, Life Sciences 2Dr. Michael E. Hogan, Ph.D., Joins Applied DNA Sciences as Vice President, Life Sciences 3Sate-of-the-Art Yuma Regional Cancer Center Officially Opens 2
... see it, soon you might not, researchers at the ... researchers have demonstrated an approximate cloaking effect created by ... brings scientists a step closer to a practical solution ... a theoretical exercise," said Harley Johnson, a Cannon Faculty ...
... paper titled “Avanta AC™ Advanced Ceramics Solutions ... This white paper outlines the challenges in ... scale, as well as the advantages of ... nanopowders are critical to a variety of ...
... Excellence in Emerging Category, LOS ANGELES, June ... that Dr. Donald Rice, Founder, President, & CEO,received ... 2008 Award in the,Emerging category in the Greater ... the award recognizes outstanding entrepreneurs who are building,and ...
Cached Biology Technology:Silicon photonic crystals key to optical cloaking, researchers say 2 SACHEM Launches New Products for High Purity Advanced Ceramic Powders : Avanta AC™ Advanced Ceramics Solutions Offer Unique Advantages over Inorganic Bases in the Manufacture of Advanced Ceramic Nanoparticles 2Agensys Founder, President, & CEO Dr. Donald Rice Named Ernst & Young Entrepreneur Of The Year(R) 2008 Award Winner for the Greater Los Angeles Area 2Agensys Founder, President, & CEO Dr. Donald Rice Named Ernst & Young Entrepreneur Of The Year(R) 2008 Award Winner for the Greater Los Angeles Area 3
(Date:7/31/2014)... the photovoltaic effect in 1839, humankind has sought to ... its own purposes. In a new research report published ... FASEB Journal , scientists may have uncovered a ... focusing on a naturally occurring combination of lipids that ... over time and across speciessuggests that this specific natural ...
(Date:7/31/2014)... New Orleans, LA Dr. Oren Tessler, Assistant Professor ... Orleans School of Medicine, is part of a team ... success rate using a method to screen and select ... than 90% of the patients who underwent this surgery ... and also got a bonus cosmetic eyelid surgery. The ...
(Date:7/31/2014)... Florida , July 31, 2014 ... develop unique and innovative smart technologies; companies turn towards ... EBAY ), Amazon.com Inc. (NASDAQ: ... Google Inc. (NASDAQ: GOOG ) and Microsoft ... authentication company focused on the growing m-commerce market, announces ...
Breaking Biology News(10 mins):Scientists shine bright new light on how living things capture energy from the sun 2Surgeons report significant migraine relief from cosmetic eyelid surgery technique 2Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 2Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 3Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 4Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 5Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 6
... has developed a calcium phosphate-based supplement that -- even ... thickness without the side effects of many current drug ... and Biomimetics and of Implant Dentistry, presented her research ... Research annual meeting on March 9, 2006. ...
... Medical Center shows that on a biochemical level, hormone-like ... the way in which certain hormones work in humans ... that afflict a third of the world's population. , ... genes involved in the development and reproduction of Caenorhabditis ...
... "pumps" associated with multi-drug resistance in bacteria may also ... a process known as quorum sensing, said researchers from ... online today in the Proceedings of the National Academy ... by these pumps may actually be similar in structure ...
Cached Biology News:New study reveals promising osteoporosis treatment 2Worm hormone discovery may aid fight against parasitic disease 2Worm hormone discovery may aid fight against parasitic disease 3Drug resistance may travel same path as quorum sensing 2
ANTI DIPHTH TOX A SU...
... EnzChek Lysozyme Assay Kit (E-22013) provides,researchers ... levels of lysozyme,activity in solution. This ... to 20 U/mL (Figure 1). The ... cell,walls, which are labeled to such ...
... is used for the synthesis of 5' ... reactions. Substitution of cap analog for a ... in vitro transcription reaction results in the ... large fraction of the transcripts. Capped mRNAs ...
The iEMS Incubator/Shaker is a high performance microplate incubator and orbital shaker. Its superior temperature control and efficient orbital shaking reduce incubation times. It can incubate up to ...
Biology Products: